相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP
Wei Zhu et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2012)
MicroRNA-128-2 targets the transcriptional repressor E2F5 enhancing mutant p53 gain of function
S. Donzelli et al.
CELL DEATH AND DIFFERENTIATION (2012)
Involvement of microRNA-93, a new regulator of PTEN/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cells
Xin Fu et al.
FEBS LETTERS (2012)
Epigenetic silencing of miR-130b in ovarian cancer promotes the development of multidrug resistance by targeting colony-stimulating factor 1
Chun Yang et al.
GYNECOLOGIC ONCOLOGY (2012)
MicroRNA-30a Sensitizes Tumor Cells to cis-Platinum via Suppressing Beclin 1-mediated Autophagy
Zhenyou Zou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Cisplatin treatment leads to changes in nuclear protein and microRNA expression
Guanglin Zhang et al.
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS (2012)
miR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2
Wei Zhu et al.
MEDICAL ONCOLOGY (2012)
MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1
L. Sun et al.
ONCOGENE (2012)
Phospho-ΔNp63α is a key regulator of the cisplatin-induced microRNAome in cancer cells
Y. Huang et al.
CELL DEATH AND DIFFERENTIATION (2011)
Overexpression of miR-200c Induces Chemoresistance in Esophageal Cancers Mediated Through Activation of the Akt Signaling Pathway
Rie Hamano et al.
CLINICAL CANCER RESEARCH (2011)
MicroRNA 376c enhances ovarian cancer cell survival by targeting activin receptor-like kinase 7: implications for chemoresistance
Gang Ye et al.
JOURNAL OF CELL SCIENCE (2011)
Upregulation of microRNA-451 increases cisplatin sensitivity of non-small cell lung cancer cell line (A549)
Hai-Bo Bian et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2011)
Platinum Interference with siRNA Non-seed Regions Fine-Tunes Silencing Capacity
Hanna K. Hedman et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2011)
miR-34a confers chemosensitivity through modulation of MAGE-A and p53 in medulloblastoma
Shyamal D. Weeraratne et al.
NEURO-ONCOLOGY (2011)
Global Analysis of DNA Methylation by Methyl-Capture Sequencing Reveals Epigenetic Control of Cisplatin Resistance in Ovarian Cancer Cell
Wei Yu et al.
PLOS ONE (2011)
Role of the Akt/mTOR survival pathway in cisplatin resistance in ovarian cancer cells
Dong-Jun Peng et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis
Linlang Guo et al.
EUROPEAN JOURNAL OF CANCER (2010)
Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin
Igor P. Pogribny et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines
Wei Zhu et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Loss of miR-200c Expression Induces an Aggressive, Invasive, and Chemoresistant Phenotype in Non-Small Cell Lung Cancer
Paolo Ceppi et al.
MOLECULAR CANCER RESEARCH (2010)
The RNA-binding protein KSRP promotes the biogenesis of a subset of microRNAs
Michele Trabucchi et al.
NATURE (2009)
Features of Mammalian microRNA Promoters Emerge from Polymerase II Chromatin Immunoprecipitation Data
David L. Corcoran et al.
PLOS ONE (2009)
MicroRNA Microarray Identifies Let-7i as a Novel Biomarker and Therapeutic Target in Human Epithelial Ovarian Cancer
Nuo Yang et al.
CANCER RESEARCH (2008)
MicroRNA expression profiling in human ovarian cancer:: miR-214 induces cell survival and cisplatin resistance by targeting PTEN
Hua Yang et al.
CANCER RESEARCH (2008)
p53-Responsive MicroRNAs 192 and 215 Are Capable of Inducing Cell Cycle Arrest
Christian J. Braun et al.
CANCER RESEARCH (2008)
Role of microRNAs in drug-resistant ovarian cancer cells
Antonio Sorrentino et al.
GYNECOLOGIC ONCOLOGY (2008)
miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells
Lin Xia et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Circulating microRNAs as stable blood-based markers for cancer detection
Patrick S. Mitchell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The resurgence of platinum-based cancer chemotherapy
Lloyd Kelland
NATURE REVIEWS CANCER (2007)
Mechanisms of resistance to cisplatin and carboplatin
David J. Stewart
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2007)
Overexpression of Dicer in precursor lesions of lung adenocarcinoma
Simion Chiosea et al.
CANCER RESEARCH (2007)
Up-regulation of dicer, a component of the microRNA machinery, in prostate adenocarcinoma
Simion Chiosea et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs
LP Lim et al.
NATURE (2005)
Modulation of the cellular pharmacology of cisplatin and its analogs by the copper exporters ATP7A and ATP7B
G Samimi et al.
MOLECULAR PHARMACOLOGY (2004)
MicroRNA genes are transcribed by RNA polymerase II
Y Lee et al.
EMBO JOURNAL (2004)
Prediction of mammalian microRNA targets
BP Lewis et al.
CELL (2003)
Cisplatin: mode of cytotoxic action and molecular basis of resistance
ZH Siddik
ONCOGENE (2003)
Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals
S Ishida et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
The activated macrophage colony-stimulating factor (CSF-1) receptor as a predictor of poor outcome in advanced epithelial ovarian carcinoma
EP Toy et al.
GYNECOLOGIC ONCOLOGY (2001)
Role for a bidentate ribonuclease in the initiation step of RNA interference
E Bernstein et al.
NATURE (2001)
Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA
AE Pasquinelli et al.
NATURE (2000)
AIS is an oncogene amplified in squamous cell carcinoma
K Hibi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
